MONTECET
Montelukast Sodium is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene CysLT1 receptor.
Levocetirizine HCL, is an orally active H1-receptor antagonist.
α-ketoisoleucine Ca salt 67 mg, α-ketoleucine Ca salt 101 mg, α-ketophenylalanine Ca salt 68 mg, α-ketovaline Ca salt 86 mg, α-hydroxymethionine Ca salt 59 mg, L-lysine acetate 105 mg, L-threonine 53 mg, L-tryptophan 23 mg, L-histidine 38 mg, L-tyrosine 30 mg. Total nitrogen content/tab: 36 mg, total Ca 1.25 mmol/tab: 50 mg
Adult ≥70 kg Chronic renal insufficiency 4-8 tab tid.
Compensated retention 4-8 tab tid w/ low protein (500-600 mg protein/kg/day close to 35-45 g) & high calorie nutrition [150-170 KJ (35-40 kCal)/kg/day].
Decompensated retention 4-8 tab tid w/ low protein (300-400 mg protein/kg/day close to 20-30 g) & high calorie nutrition [150-170 KJ (35-40 kCal)/kg/day].
Chronic renal insufficiency w/ the following conditions: given w/ high calorie, low protein food ≤40 g daily; compensated or decompensated retention; GFR of 5-50 mL/min.
FDA Registration number: DRP-5901-14
Manufacturer: West-Coast Pharmaceutical Works Ltd.
© 2019, Quadgen Pharmaceutical. All rights reserved. Developed by JG DevArt.